Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper-Reference-Cited by-同舟云学术

Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper

Published:2022-10 Issue:4 Volume:77 Page:1161-1197
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Marjot Thomas,Eberhardt Christiane S.^ORCID,Boettler Tobias,Belli Luca S.^ORCID,Berenguer Marina^ORCID,Buti Maria,Jalan Rajiv^ORCID,Mondelli Mario U.,Moreau Richard^ORCID,Shouval Daniel,Berg Thomas^ORCID,Cornberg Markus^ORCID

Funder

Pfizer

Wellcome Trust

European Association for the Study of the Liver

Publisher

Elsevier BV

Subject

Hepatology

Reference333 articles.

1. Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper;Boettler;JHEP Rep,2020

2. Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic;Boettler;JHEP Rep,2020

3. EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients;Cornberg;J Hepatol,2021